IVF News

Click here for Registration

3pm ET/ 7pm UK/ 8pm CET, Tuesday 11th Mar 2025 CHECK REGIONAL TIME

Moderators: Simon Lumsdon, Andrew Thomson

Panelist: Elina Roumian

Presenters:
Dr Sarah Lensen: IVF Add-Ons: Hope, Hype, and Hard Evidence
Madison Bailey: “Breaking Bad News- The trainee’s perspective" 
Dr Lize Leunens: Polyparenthood and coparenting: the future
for fertility centres?

Q and A

REGISTER HERE

In a critical step for reproductive healthcare, a Georgia House committee has unanimously advanced a bill that would formally protect access to in-vitro fertilization (IVF) under state law. While this may seem like a routine political move, its significance for the scientific and medical communities — particularly those working in reproductive medicine — is profound.

Why IVF Protections Matter

IVF is a cornerstone of modern reproductive medicine, representing decades of scientific progress in fertility treatments. The process involves retrieving eggs from a woman’s ovaries, fertilizing them in a laboratory setting, and transferring resulting embryos into the uterus to achieve pregnancy. It’s a technique that has helped millions of families around the world conceive, and it continues to evolve as research advances.

Despite its widespread use and success, IVF has increasingly become entangled in legal and political debates due to its connection to embryo creation and storage. During a typical IVF cycle, multiple embryos are often created to maximize the chances of success. Those not immediately implanted can be frozen for future use, donated for research, or discarded. This last step — the potential destruction of unused embryos — has made IVF a target in states with restrictive abortion laws, where the legal definition of personhood has been expanded to include fertilized eggs.

Scientific Concerns in the Absence of Clear Legal Protections

For reproductive scientists, embryologists, and fertility specialists, legal uncertainty around embryo status creates a chilling effect. Scientific advancements depend on the ability to apply evidence-based best practices — from embryo grading and genetic testing to innovations that improve success rates and reduce the physical and emotional toll on patients. If ambiguous laws or philosophical debates over embryo personhood begin to shape medical protocols, the ability to provide optimal, individualized care is compromised.

This is why Georgia’s proposed law matters. By explicitly safeguarding the right to access IVF, the legislation creates a layer of legal clarity and reassurance for reproductive professionals. It also reinforces that fertility treatments are a legitimate and essential aspect of healthcare, guided by medical and scientific expertise rather than ideological interpretation.

Aligning Policy with Scientific Reality

Modern IVF practices are built on extensive research into embryo viability, genetic screening, cryopreservation, and implantation techniques. The ability to make evidence-based decisions — including determining which embryos are most likely to result in a healthy pregnancy — is a crucial part of achieving high success rates and minimizing unnecessary procedures.

When laws threaten to override these scientific processes, clinics are forced to practice defensively, altering protocols not for medical reasons, but to avoid legal risk. This can hinder innovation, slow the adoption of new technologies, and, ultimately, harm patients.

A Broader Signal to the Scientific Community

Beyond Georgia’s borders, this legislation sends a message to researchers and clinicians across the country: scientific expertise matters, and policies can be crafted to align with it. As the field of reproductive medicine continues to advance — from improved embryo culture techniques to new frontiers like gene editing and regenerative medicine — scientists need assurance that their work will be supported by a stable legal framework.

Codifying IVF protections into state law recognizes the vital role of science in addressing infertility, one of the most common medical challenges faced by hopeful parents. It also reinforces the importance of separating evidence-based reproductive care from ideological disputes over when life begins, a debate that risks oversimplifying both the science and the human experience of fertility treatment.

Protecting Progress and Innovation

For the scientific community, Georgia’s proposed law is about much more than politics. It’s about protecting the space where science and medicine intersect — the space where innovation happens. When policymakers acknowledge and safeguard that space, it creates an environment where scientists, clinicians, and patients can focus on what truly matters: advancing care, improving outcomes, and helping families grow.

Sources

24 February 2025. Georgia Recorder

• Georgia House panel unanimously backs proposed state law to protect IVF procedures

IVF on Demand Equipment (IVFOD) Acquires Nationwide IVF Service to Expand Reach and Enhance Fertility Laboratory Solutions

Narberth, PA – IVF On Demand Equipment, a leading provider of IVF products and laboratory equipment, has acquired Nationwide IVF Service, an independent IVF laboratory equipment service provider. The acquisition significantly expands IVFOD’s reach and strengthens its position as a leading force in the fertility industry by integrating Nationwide IVF Service's established network and expertise. The combined entity will operate as a subsidiary of IVFOD.

This acquisition brings together IVF on Demand's unique expertise in the Assisted Reproductive Technology markets along with Nationwide IVF Service’s years of specialized technical background. 

“This acquisition marks a pivotal moment in our growth strategy,” said Brian Leonard, CEO of IVF on Demand. “By acquiring Nationwide IVF Service, we are significantly expanding our reach and enhancing our ability to provide comprehensive and accessible solutions. This combination of our expertise and background will create an unparalleled experience for our customers.”

“We are excited to become part of the IVFOD family,” said Matt Haley, CEO of Nationwide IVF Service. “This acquisition allows us to leverage IVFOD’s innovative platform to better serve our clients and expand access to our services. We believe this is a win-win for everyone involved in IVF, our commitment to excellent service will remain the same.”

The acquisition is expected to be completed February 28, 2025, subject to customary closing conditions and regulatory approvals. 

About IVF on Demand Equipment

IVF On Demand Equipment is a provider of equipment and products utilized in the Assisted Reproductive Human Clinical, Animal, and Research Markets.  IVFOD focuses on a consultative approach to collaborate with customers on what is best for their needs.  The addition of Nationwide IVF Services broadens the reach and allows for increased growth. 

About Nationwide IVF Service

Nationwide IVF Service, (Nationwide) is the first independent service provider of IVF laboratory equipment. Nationwide is the only all-in-one source solution provider for IVF equipment, preventive maintenance, repair, installation and relocation services. Our programs typically save IVF labs 30-40% on service costs, and we are qualified, experienced, and affordable.

Click here for register

Training Batch Schedule April 2025 

Batch - IV :    16th  to 30th April

The International School of Embryology a unit of Chennai Fertility Centre and Research Institute was established to offer training in Advanced Reproductive Techniques and Embryology for clinicians and embryologists. It will help them to know in-depth knowledge and have good hands-on training. The members of our teaching faculty aim to bring Clinician and Embryologists to the highest level of knowledge about Assisted Reproductive Technology and practical capability.

Our courses cover basics in Andrology, Embryology, ICSI & Cryosciences (Hands-on).

Limited Seats. For admission Contact  9003111598 / 8428278218 

3pm ET/ 7pm UK/ 8pm CET, Tuesday 11th Mar 2025 CHECK REGIONAL TIME

Moderators: Simon Lumsdon, Andrew Thomson

Panelist: Elina Roumian

Presenters:
Dr Sarah Lensen: IVF Add-Ons: Hope, Hype, and Hard Evidence
Madison Bailey: “Breaking Bad News- The trainee’s perspective" 
Dr Lize Leunens: Polyparenthood and coparenting: the future
for fertility centres?

Q and A

REGISTER HERE

On February 18, 2025, President Donald Trump signed an executive order aimed at expanding access to in vitro fertilization (IVF) and reducing its associated costs. This directive instructs the Domestic Policy Council to develop recommendations within 90 days to protect IVF access and significantly lower out-of-pocket expenses and health plan costs for such treatments. The order emphasizes the administration’s commitment to supporting family formation by making fertility treatments more affordable and accessible. 

IVF is a widely used assisted reproductive technology that involves combining eggs and sperm in a laboratory setting to create embryos, which are then implanted into the uterus. Despite its prevalence, the financial burden of IVF remains substantial, with costs ranging from $12,000 to $25,000 per cycle, and multiple cycles often necessary to achieve a successful pregnancy. Currently, insurance coverage for IVF is limited; only a quarter of employers offer coverage, and few states mandate insurance plans to include IVF treatments. The federal government provides limited coverage for military personnel, veterans, and federal employees. 

The executive order comes in response to declining fertility rates in the United States. Data from the Department of Health and Human Services indicates that more than 85,000 infants were born through IVF in 2021. However, the general U.S. fertility rate has reached a historic low, dropping 3% in 2023 compared to 2022, and consistently decreasing by 2% annually from 2014 to 2020. This trend underscores the need for accessible and affordable fertility treatments to support individuals and couples desiring to start families. 

During his previous term, President Trump implemented policies to support family growth, such as doubling the child tax credit and allowing new parents to withdraw up to $5,000 from retirement accounts without penalty following the birth or adoption of a child. The current executive order builds upon these initiatives by addressing the financial challenges associated with IVF, aiming to remove unnecessary statutory or regulatory barriers that contribute to the high costs of fertility treatments. 

While the executive order outlines the administration’s intent to make IVF more accessible and affordable, it does not specify the exact mechanisms for cost reduction or coverage expansion. The forthcoming recommendations from the Domestic Policy Council are expected to provide detailed strategies to achieve these objectives, potentially involving legislative changes, insurance reforms, or federal funding adjustments to alleviate the financial strain on individuals seeking IVF treatments.

Sources

18 February 2025. The Whitehouse

• Expanding access to in vitro fertilisation

18 February 2025. The Whitehouse

• President Donald Trump expands access to in vitro fertilisation

18 February 2025. Reuters

• Trump signs executive order seeking to expand IVF access

19 February 2025. MSN

• Donald Trump's IVF executive order explained: What you need to know

18 February 2025. CNN

• Trump signs executive order aimed at expanding IVF access and reducing costs

19 February 2025. The Guardian

• Trump's IVF order: A PR move that gives pronatalists cause for cheer

19 February 2025. The Independent

• Trump has signed an executive order to expand access to IVF. What does it mean?

For Online Registration, please click on the Registration Link.